Physician profile
Michael Stewart
NPI 1134333255
$9,565.99
in general payments reported to CMS, 2019-2025
13 companies · $83.68 in 2025
The $83.68 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.81 · 2022: $52.85 · 2023: $9,266 · 2024: $75.93 · 2025: $83.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Food and Beverage: $656 · Travel and Lodging: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Food and Beverage | $655.57 |
| Travel and Lodging | $269.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,117.96 | 2021-2023 | Davinci Xi, Da Vinci Surgical System |
| Stryker Corporation | $69.23 | 2025 | Clottriever Bold Catheter |
| Kerecis Limited | $67.87 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Becton, Dickinson and Company | $64.51 | 2023 | Phasix Mesh |
| Davol INC. | $62.60 | 2023 | Phasix Mesh |
| Allergan, INC. | $36.65 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.40 | 2022 | |
| Organogenesis INC. | $31.58 | 2024 | Affinity |
| Medtronic, INC. | $24.61 | 2023 | Sonicision |
| Aurinia Pharma U.S., INC. | $18.65 | 2023 | Lupkynis |
| Angiodynamics, INC. | $16.58 | 2023 | Venacure 1470 Pro |
| Solventum Corporation | $14.45 | 2025 | Prevena |
| Bard Peripheral Vascular, INC. | $7.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.